ASX IPO review, charting analysis on six key stocks, top financial-planning issues, benefits of biotech, outlook for emerging miners, gold
ASX
Log in to MyASX
Investor Update
In this month's edition of Investor Update, read about key investment-planning issues to watch, how to invest in the world's biggest pharmaceutical companies, how the market outlook will present opportunity for patient, long-term investors; and more.
icon-heading Market views
ASX review of sharemarket floats

Kate Galpin, ASX - Read more >

About: Australia in global top five for Initial Public Offerings in 2018.
Featuring: IPOs
10 key themes that will determine 2019 sharemarket outcomes

Oscar Oberg, Wilson Asset Management - Read more >

About: Bearish outlook will present opportunity for patient, long-term investors.
Featuring: Australian equities
What the charts say about six of Australia’s best-known stocks

Nick Radge, The Chartist - Read more >

About: Technical analysis on CBA, AMP, BHP, Woolworths, Telstra and Qantas.
Featuring: Australian Equities
Top issues that financial advisers see this year
Ishara Rupasinghe, Dixon Advisory and Clayton Daniel, Adviser Ratings - Read more >
About: ASX Investor Update asked two experts about key investment-planning issues to watch.
Featuring: Wealth management
Exciting year ahead for biotech
Tanushree Jain, Bell Potter Securities - Read more >
About: Record number of drugs approved as much-needed treatments get to market faster.
Featuring: Lifesciences
How to invest in the world's biggest pharmaceutical companies
Kris Walesby, ETFS Management - Read more >
About: Exchange Traded Funds provide diversified exposure to global lifescience companies.
Featuring: Lifesciences
icon-heading Trader's corner
Signs of renewed optimism in junior resources
Gavin Wendt, MineLife - Read more >
About: Bad news abounds, but underlying fundamentals for most commodities remain robust.
Featuring: Small resources
Will gold shine in 2019?
David Lennox, Fat Prophets - Read more >
About: Solid gains in precious metal likely – but keep a close eye on US dollar.
Featuring: Gold
icon-heading ASX and partner events
ASX CEO Connect
CEO Connect is now sold out, however you can still sign up for the free live stream.
Sign up >
icon-heading Upcoming IPOs and fund data
Upcoming Floats
Upcoming listings - your guide to upcoming floats
A summary on companies that are raising capital and have applied for official admission to ASX.
Read more >
Managed Fund Report
ASX Managed Funds report
Report provides recent admissions, performance matrix, trading activity, plus LIC NTA report.
Read more >
managed-fund-repor-264x150t
Bond, Hybrid, Warrant & Equity Derivatives report
Bonds - reports and updates >
Hybrids - reports, listings and updates >
Warrants - latest report >
Equity Derivatives - latest report >
icon-heading New investors
ASX Sharemarket Game
Now in its 42nd year, the Game is your best place to learn about the sharemarket in a fun and safe way. Take $50,000 virtual dollars to invest in over 200 companies, test your strategies, create a league and play alongside your friends.
Register now >
Visit:
asx.com.au
Edit details:
Login to MyASX
Follow us on:
t Y LinkedIn
The views, opinions or recommendations of the authors in these articles are solely those of the authors and do not in any way reflect the views, opinions, recommendations, of ASX Limited ABN 98 008 624 691 and its related bodies corporate (“ASX”). ASX makes no representation or warranty with respect to the accuracy, completeness or currency of the content. The content is for educational purposes only and does not constitute financial advice. Independent advice should be obtained from an Australian financial services licensee before making investment decisions. To the extent permitted by law, ASX excludes all liability for any loss or damage arising in any way including by way of negligence.
© Copyright 2019 ASX Limited ABN 98 008 624 691. All rights reserved 2019.
http://click.marketing.asx.com.au/profile_center.aspx?qs=ddd90f8e6db7bf19a5c92cb5887796d1bb8f9d0d23edb7cb1311f88a4cf96835fa4ff6940b60b84233713a073e405e3643ac227bcf58acbc